Overcoming Skepticism in ML-Driven Biologics Innovation

This chapter explores the journey of a startup merging machine learning with synthetic biology, detailing the challenges of gaining investor confidence amid industry skepticism. It highlights the significance of overcoming doubts and crafting a compelling vision to secure early funding.